Hims & Hers faces battles as federal regulators and Novo Nordisk move to disrupt its sale of compounded weight loss drugs.
Hims & Hers under fire over copycat weight loss drugs
Recommended
Welcome to LJ News Opinions, where breaking news stories have captivated us for over 20 years.
Join us in this journey of sharing points of view about the news – read, react, engage, and unleash your opinion!